Portal is developing a universal cell engineering platform that leverages proprietary membrane technology for drug discovery and cell therapy applications
Portal is developing a universal cell engineering platform that leverages proprietary membrane technology for drug discovery and cell therapy applications.
The top three firms on F4's Biotech & Life Sciences investor list.